Viewing Study NCT01779050


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-04-08 @ 5:56 AM
Study NCT ID: NCT01779050
Status: TERMINATED
Last Update Posted: 2022-11-01
First Post: 2013-01-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Sponsor: Washington University School of Medicine
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 201309084
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View